Cell Therapeutics (CTIC) Files $150M Mixed Shelf
Tweet Send to a FriendGet Alerts CTIC Hot Sheet
Up)
Trade CTIC Now!
Cell Therapeutics, Inc. (Nasdaq: CTIC) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $150 million of Common Stock, Preferred Stock, Debt Securities, Warrants, Rights, Units, or any combination thereof.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment
- StreetInsider.com Pre-Open Movers 6/17: (KNDI) (NFLX) (AMD) Higher; (FOLD) (TEX) (ARMH) Lower (more...)
- Gladstone Commercial (GOOD) Prices Upsized 1.32M Common Stock Offering
Create E-mail Alert Related Categories
Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
